Anxiogenic action of caffeine: An experimental study in rats

Journal of Psychopharmacology

Volumn 11, Issue 3, 1997, Pages 219-224

  Bhattacharya, Salil K ^a   Satyan, Kalkunte S ^a   Chakrabarti, Amit ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Anxiety; Caffeine; Caffeine withdrawal anxiety; Lorazepam; Tolerance to caffeine; Tribulin; Yohimbine

Indexed keywords

CAFFEINE; LORAZEPAM; YOHIMBINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DEFECATION; DOSE RESPONSE; DRUG TOLERANCE; DRUG WITHDRAWAL; FEEDING BEHAVIOR; IMMOBILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MOBILIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION;

ANIMALS; ANXIETY; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DRUG TOLERANCE; EXPLORATORY BEHAVIOR; MALE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, WISTAR; SOCIAL BEHAVIOR; SUBSTANCE WITHDRAWAL SYNDROME; YOHIMBINE;

EID: 0030827837     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119701100304     Document Type: Article

References (41)

1. American Psychiatric Association (1987) Caffeine intoxication. In Diagnostic and statistical manual of mental disorders, 3rd edn (revised). American Psychiatric Association, Washington D.C.
2. Arnaud M J (1987) The pharmacology of caffeine. Prog Drug Res 31: 273-313
3. Baldwin H A, File S E (1989) Caffeine-induced anxiogenesis: role of adenosine, benzodiazepine and noradrenergic receptors. Pharmac Biochem Behav 32: 181-186
4. Berkowitz B A, Travers J H, Spector S (1970) Release of norepinephrine in the CNS by theophylline and caffeine. Eur J Pharmac 10: 64-71
5. Bhattacharya SK (1995) Anxiogenic activity of centrally administered scorpion (Mesobuthus tamulus) venom in rats. Toxicon 33: 1491-1499
6. Bhattacharya S K, Mitra S K (1992) Anxiogenic action of quinine: an experimental study in rodents. Ind J Exp Biol 30: 33-37
7. Bhattacharya S K, Acharya S B (1993) Further investigations on the anxiogenic action of isatin. Biogenic Amines 9: 453-463
8. 3 receptors. In Dhawan B N, Srimal R C, Raghubir R, Rapaka R S (eds), Recent advances in the study of neurotransmitter receptors. Central Drug Research Institute, Lucknow, pp. 70-80
9. Bhattacharya S K, Mitra S K, Acharya S B (1991) Anxiogenic action of isatin, a putative biological factor in rodents. J Psychopharmac 5: 202-206
10. Bhattacharya S K, Chakrabarti A, Sandler M, Glover V (1995a) Rat brain MAO A and MAO B inhibitory (tribulin) activity during drug withdrawal anxiety. Neurosci Letts 199: 103-106
11. Bhattacharya S K, Mohan Rao PJ R, Sen A P (1995b) Anxiogenic activity of intraventricularly administered bradykinin in rats. J Psychopharmac 9: 348-354
12. Bhattacharya SK, Chakrabarti A, Sandler M, Glover V (1996) Anxiolytic activity of intraventricularly administered atrial natriuretic peptide in the rat. Neuropsychopharmacology 15: 199-206
13. Bodnoff S R, Suranyi-Cadotte B, Aitken D H, Quirion R, Meaney M J (1988) The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology 95: 298-302
14. Boulenger J P, Uhde T W (1982) Caffeine consumption and anxiety: preliminary results of a survey comparing patients with anxiety disorders and normal controls. Psychopharmac Bull 18: 53-57
15. Bruce M S (1990) The anxiogenic effects of caffeine. Postgrad Med J 66 (Suppl. 21): S18-S24
16. Bruce M S, Scott N, Lader M, Marks V (1986) The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects. Br J Clin Pharmac 22: 81-87
17. Charney D S, Heninger G R, Redmond D E (1983) Yohimbine induced anxiety and increased noradrenaline function in humans. Effects of diazepam and clonidine. Life Sci 33: 19-29
18. Charney D S, Galloway M P, Heninger G R (1984) The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans. Life Sci 35: 134-144
19. Collis M G, Hourani S M O (1992) Adenosine receptor subtypes. Trends Pharmac Sci 14: 360-366
20. File S E (1988) How good is the social interaction test of anxiety? In Simon P, Soubrie P, Wildlocher D (eds), Selected models of anxiety, depression and psychosis. Karger, Basel, pp. 151-166
21. Greden J F, Fontaine P, Lubetsky M, Chamberlin K (1979) Anxiety and depression associated with caffeinism among psychiatric patients. Am J Psychiat 135: 963-966
22. Griffiths R R, Woodson P P (1988) Caffeine physical dependence; a review of human and laboratory animal studies. Psychopharmacology 94: 437-451
23. Hollingsworth H C (1912) The influence of caffeine on mental and motor efficiency. Archs Psychol 22: 1-166
24. Imauzumi S, Miyanaki S, Onodera K (1994) Effects of xanthine derivatives in a light-dark test in mice and the contribution of adenosine receptors. Meth Find Exp Clin Pharmac 16: 539-644
25. Jain N, Kemp N, Adeyemo O, Buchanan P, Stone TW (1995) Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmac 116: 2127-2133
26. Johnston A L, Baldwin H E, File S E (1988) Measures of anxiety and stress in the rat following chronic treatment with yohimbine. J Psychopharmac 2: 33-38
27. Kaplan H I, Freeman A M, Sadock B J (eds) (1984) Comprehensive textbook of psychiatry, Vol. 1, 4th edn. Williams and Wilkins, Baltimore, MD, pp. 926-1031
28. Lal H, Bennett D A, Shearman G, Horvat A (1983) Yohimbine: behavioural and biochemical properties common with anxiogenic beta-carbolines. Soc Neurosci Abstr 9: 437
29. Lapin I P, Politi V (1993) Anxiolytic effect of indole-3-pyruvic acid (IPA) in mice. Pharmac Res 28: 129-134
30. Lister R G (1990) Ethologically based animal models of anxiety disorders. Pharmac Therap 46: 321-340
31. Lydiard R B (1994) Neuropeptides and anxiety: focus on cholecystokinin. Clin Chem 40: 315-318
32. MacCallum W A G (1979) Excess coffee and anxiety states. Int J Soc Psychiat 25: 209-210
33. Nehlig A, Daval J-L, Debry G (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 17: 139-170
34. Nutt D J (1990) The pharmacology of human anxiety. Pharmac Therap 47: 233-266
35. Pellow S, Chopin P, File S E, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14: 149-167
36. Prince D A, Stevens C F (1992) Adenosine decreases neurotransmitter release at central synapses. Proc Natl Acad Sci USA 89: 8586-8590
37. Rickels K, Schweizer E E (1987) Current pharmacotherapy of anxiety and panic. In Meltzer H Y (ed.), Psychopharmacology: the third generation of progress. Raven Press, New York, pp. 1193-1203
38. Thiebot M H, Daugoumau L, Richard G, Puech A J (1991) Safety signal withdrawals a behaviour paradigm sensitive to both 'anxiolytic' and 'anxiogenic' drugs under identical experimental conditions. Pychopharmacology 103: 415-424
39. Treit D (1985) Animal models for the study of anti-anxiety agents: a review. Neurosci Biobehav Rev 9: 203-222
40. Uhde T W, Boulenger J P, Jimerson D C, Post R M (1984) Caffeine: relationship to human anxiety, plasma MHPG and cortisol. Psychopharmac Bull 20: 426-430
41. Vellucci S V, Webster R A (1984) Antagonism of caffeine-induced seizures in mice by RO15-1788. Eur J Pharmac 97: 289-293